Ignite Creation Date:
2024-05-06 @ 12:27 AM
Last Modification Date:
2024-10-26 @ 10:50 AM
Study NCT ID:
NCT01578239
Status:
COMPLETED
Last Update Posted:
2022-04-04
First Post:
2012-04-10
Brief Title:
A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable Progressive Somatostatin Receptor Positive Midgut Carcinoid Tumours
Sponsor:
Advanced Accelerator Applications
Organization:
Advanced Accelerator Applications